title: Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
authors.affiliation: Columbia-Presbyterian Medical Center, New York, New York 10032.
authors.forename: P
authors.initials: P
authors.lastname: Greene
authors.forename: L
authors.initials: L
authors.lastname: Cote
authors.forename: S
authors.initials: S
authors.lastname: Fahn
mesh_terms: D000368:Aged; D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002230:Carbidopa / Q000009:adverse effects* / Q000627:therapeutic use; D003024:Clozapine / Q000009:adverse effects / Q000627:therapeutic use*; D003704:Dementia / Q000139:chemically induced / Q000188:drug therapy / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009460:Neurologic Examination / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy* / Q000523:psychology; D011605:Psychoses, Substance-Induced / Q000188:drug therapy* / Q000523:psychology
chemical_list: D000978:Antiparkinson Agents; D004338:Drug Combinations; C009265:carbidopa, levodopa drug combination; D007980:Levodopa; D003024:Clozapine; D002230:Carbidopa